Advertisement
Screener

BIOMARIN PHARMACEUTICAL INC (BMRN) Increase (Decrease) in Other Operating Liabilities

BIOMARIN PHARMACEUTICAL INC Increase (Decrease) in Other Operating Liabilities

BIOMARIN PHARMACEUTICAL INC (BMRN) reported Increase (Decrease) in Other Operating Liabilities of $6.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-06

  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was -$2.04M, a 158.74% decline year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $8.70M, a 320.69% increase year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was -$7.02M, a 254.96% decline year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was $16.36M, a 364.63% increase year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for fiscal 2025 was $14.87M, a 0.73% increase from fiscal 2024.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for fiscal 2024 was $14.76M, a 37.41% decline from fiscal 2023.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for fiscal 2023 was $23.59M, a 240.18% increase from fiscal 2022.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for fiscal 2022 was $6.93M.
Period endIncrease (Decrease) in Other Operating Liabilities 3 monthIncrease (Decrease) in Other Operating Liabilities 6 monthIncrease (Decrease) in Other Operating Liabilities 9 monthIncrease (Decrease) in Other Operating Liabilities 12 monthIncrease (Decrease) in Other Operating Liabilities 12 month as first filed
2026-06-30-$2.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$6.67M
10-Q · filed 2026-08-06
-$356.00K
derived: sum of 3 quarters · filed 2026-08-06
$16.00M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$8.70M
10-Q · filed 2026-05-05
$1.68M
derived: sum of 2 quarters · filed 2026-05-05
$18.04M
derived: sum of 3 quarters · filed 2026-05-05
$21.50M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$7.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$9.33M
derived: sum of 2 quarters · filed 2026-02-26
$12.80M
derived: sum of 3 quarters · filed 2026-08-06
$14.87M
10-K · filed 2026-02-26
2025-09-30$16.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$19.82M
derived: sum of 2 quarters · filed 2026-08-06
$21.89M
10-Q · filed 2025-10-28
$26.42M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$3.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$5.54M
10-Q · filed 2026-08-06
$10.07M
derived: sum of 3 quarters · filed 2026-08-06
$13.59M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$2.07M
10-Q · filed 2026-05-05
$6.60M
derived: sum of 2 quarters · filed 2026-05-05
$10.12M
derived: sum of 3 quarters · filed 2026-05-05
$13.52M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$4.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$8.05M
derived: sum of 2 quarters · filed 2026-02-26
$11.45M
derived: sum of 3 quarters · filed 2026-02-26
$14.76M
10-K · filed 2026-02-26
2024-09-30$3.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$6.92M
derived: sum of 2 quarters · filed 2025-10-28
$10.23M
10-Q · filed 2025-10-28
$19.48M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$3.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$6.71M
10-Q · filed 2025-08-05
$15.96M
derived: sum of 3 quarters · filed 2026-02-26
$23.19M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$3.31M
10-Q · filed 2025-05-02
$12.56M
derived: sum of 2 quarters · filed 2026-02-26
$19.79M
derived: sum of 3 quarters · filed 2026-02-26
$22.63M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$9.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$16.48M
derived: sum of 2 quarters · filed 2026-02-26
$19.32M
derived: sum of 3 quarters · filed 2026-02-26
$23.59M
10-K · filed 2026-02-26
2023-09-30$7.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
$10.07M
derived: sum of 2 quarters · filed 2024-10-31
$14.33M
10-Q · filed 2024-10-31
$24.52M
derived: sum of 4 quarters · filed 2025-02-24
2023-06-30$2.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05
$7.10M
10-Q · filed 2024-08-05
$17.29M
derived: sum of 3 quarters · filed 2025-02-24
$15.61M
derived: sum of 4 quarters · filed 2025-02-24
2023-03-31$4.26M
10-Q · filed 2024-04-26
$14.45M
derived: sum of 2 quarters · filed 2025-02-24
$12.77M
derived: sum of 3 quarters · filed 2025-02-24
$9.48M
derived: sum of 4 quarters · filed 2025-02-24
2022-12-31$10.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24
$8.51M
derived: sum of 2 quarters · filed 2025-02-24
$5.22M
derived: sum of 3 quarters · filed 2025-02-24
$6.93M
10-K · filed 2025-02-24
2022-09-30-$1.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$4.96M
derived: sum of 2 quarters · filed 2023-11-02
-$3.25M
10-Q · filed 2023-11-02
-$6.86M
derived: sum of 4 quarters · filed 2024-02-26
2022-06-30-$3.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
-$1.58M
10-Q · filed 2023-08-02
-$5.18M
derived: sum of 3 quarters · filed 2024-02-26
-$5.50M
derived: sum of 4 quarters · filed 2024-02-26
2022-03-31$1.71M
10-Q · filed 2023-04-28
-$1.90M
derived: sum of 2 quarters · filed 2024-02-26
-$2.21M
derived: sum of 3 quarters · filed 2024-02-26
-$3.93M
derived: sum of 4 quarters · filed 2024-02-26
2021-12-31-$3.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
-$3.92M
derived: sum of 2 quarters · filed 2024-02-26
-$5.64M
derived: sum of 3 quarters · filed 2024-02-26
-$3.34M
10-K · filed 2024-02-26
2021-09-30-$316.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28
-$2.04M
derived: sum of 2 quarters · filed 2022-10-28
$269.00K
10-Q · filed 2022-10-28
-$15.98M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30-$1.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$585.00K
10-Q · filed 2022-08-04
-$15.67M
derived: sum of 3 quarters · filed 2023-02-27
-$12.38M
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31$2.30M
10-Q · filed 2022-04-29
-$13.95M
derived: sum of 2 quarters · filed 2023-02-27
-$10.66M
derived: sum of 3 quarters · filed 2023-02-27
-$9.87M
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31-$16.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
-$12.97M
derived: sum of 2 quarters · filed 2023-02-27
-$12.17M
derived: sum of 3 quarters · filed 2023-02-27
-$7.03M
10-K · filed 2023-02-27
-$6.87M
10-K · filed 2021-02-26
2020-09-30$3.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29
$4.08M
derived: sum of 2 quarters · filed 2021-10-29
$9.22M
10-Q · filed 2021-10-29
$9.97M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$794.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$5.94M
10-Q · filed 2021-07-30
$6.68M
derived: sum of 3 quarters · filed 2022-02-25
-$1.21M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$5.14M
10-Q · filed 2021-04-30
$5.89M
derived: sum of 2 quarters · filed 2022-02-25
-$2.01M
derived: sum of 3 quarters · filed 2022-02-25
$6.80M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$742.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
-$7.15M
derived: sum of 2 quarters · filed 2022-02-25
$1.65M
derived: sum of 3 quarters · filed 2022-02-25
$3.13M
10-K · filed 2022-02-25
2019-09-30-$7.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$912.00K
derived: sum of 2 quarters · filed 2020-11-06
$2.39M
10-Q · filed 2020-11-06
$7.56M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$8.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$10.28M
10-Q · filed 2020-08-05
$15.45M
derived: sum of 3 quarters · filed 2021-02-26
$16.53M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$1.47M
10-Q · filed 2020-05-01
$6.64M
derived: sum of 2 quarters · filed 2021-02-26
$7.72M
derived: sum of 3 quarters · filed 2021-02-26
$10.80M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31$5.17M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26
$6.25M
derived: sum of 2 quarters · filed 2021-02-26
$9.32M
derived: sum of 3 quarters · filed 2021-02-26
$8.91M
10-K · filed 2021-02-26
2018-09-30$1.08M
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04
$4.15M
derived: sum of 2 quarters · filed 2019-11-04
$3.74M
10-Q/A · filed 2019-11-04
$6.04M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$3.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$2.66M
10-Q · filed 2019-08-02
$4.96M
derived: sum of 3 quarters · filed 2020-02-27
$5.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$408.00K
10-Q · filed 2019-04-29
$1.89M
derived: sum of 2 quarters · filed 2020-02-27
$1.93M
derived: sum of 3 quarters · filed 2020-02-27
$2.64M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$2.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$2.33M
derived: sum of 2 quarters · filed 2020-02-27
$3.05M
derived: sum of 3 quarters · filed 2020-02-27
$5.79M
10-K · filed 2020-02-27
2017-09-30$38.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26
$753.00K
derived: sum of 2 quarters · filed 2018-10-26
$3.50M
10-Q · filed 2018-10-26
$2.54M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$715.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
$3.46M
10-Q · filed 2018-08-03
$2.50M
derived: sum of 3 quarters · filed 2019-02-28
$6.10M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$2.74M
10-Q · filed 2018-04-27
$1.78M
derived: sum of 2 quarters · filed 2019-02-28
$5.39M
derived: sum of 3 quarters · filed 2019-02-28
$1.95M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$962.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$2.65M
derived: sum of 2 quarters · filed 2019-02-28
-$799.00K
derived: sum of 3 quarters · filed 2019-02-28
-$5.41M
10-K · filed 2019-02-28
2016-09-30$3.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
$163.00K
derived: sum of 2 quarters · filed 2017-10-31
-$4.45M
10-Q · filed 2017-10-31
-$4.49M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30-$3.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
-$8.06M
10-Q · filed 2017-08-02
-$8.10M
derived: sum of 3 quarters · filed 2018-02-26
-$14.38M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31-$4.61M
10-Q · filed 2017-05-04
-$4.66M
derived: sum of 2 quarters · filed 2018-02-26
-$10.94M
derived: sum of 3 quarters · filed 2018-02-26
-$13.05M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31-$43.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
-$6.32M
derived: sum of 2 quarters · filed 2018-02-26
-$8.44M
derived: sum of 3 quarters · filed 2018-02-26
$747.00K
10-K · filed 2018-02-26
2015-09-30-$6.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$8.40M
derived: sum of 2 quarters · filed 2016-11-03
$790.00K
10-Q · filed 2016-11-03
$4.00M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30-$2.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$7.07M
10-Q · filed 2016-08-08
$10.28M
derived: sum of 3 quarters · filed 2017-02-27
$11.35M
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31$9.19M
10-Q · filed 2016-05-02
$12.39M
derived: sum of 2 quarters · filed 2017-02-27
$13.46M
derived: sum of 3 quarters · filed 2017-02-27
$11.69M
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31$3.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$4.28M
derived: sum of 2 quarters · filed 2017-02-27
$2.51M
derived: sum of 3 quarters · filed 2017-02-27
$3.09M
10-K · filed 2017-02-27
2014-09-30$1.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
-$703.00K
derived: sum of 2 quarters · filed 2015-11-02
-$116.00K
10-Q · filed 2015-11-02
$4.08M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$1.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
-$1.18M
10-Q · filed 2015-08-05
$3.01M
derived: sum of 3 quarters · filed 2016-02-29
$6.36M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$587.00K
10-Q · filed 2015-05-05
$4.78M
derived: sum of 2 quarters · filed 2016-02-29
$8.13M
derived: sum of 3 quarters · filed 2016-02-29
$7.37M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$4.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$7.54M
derived: sum of 2 quarters · filed 2016-02-29
$6.79M
derived: sum of 3 quarters · filed 2016-02-29
$9.56M
10-K · filed 2016-02-29
2013-09-30$3.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28
$2.59M
derived: sum of 2 quarters · filed 2014-10-28
$5.37M
10-Q · filed 2014-10-28
$2.78M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30-$757.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31
$2.02M
10-Q · filed 2014-07-31
-$574.00K
derived: sum of 3 quarters · filed 2015-03-02
$3.82M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$2.77M
10-Q · filed 2014-05-02
$183.00K
derived: sum of 2 quarters · filed 2015-03-02
$4.57M
derived: sum of 3 quarters · filed 2015-03-02
$7.42M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31-$2.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$1.80M
derived: sum of 2 quarters · filed 2015-03-02
$4.65M
derived: sum of 3 quarters · filed 2015-03-02
$6.03M
10-K · filed 2015-03-02
2012-09-30$4.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28
$7.24M
derived: sum of 2 quarters · filed 2013-10-28
$8.63M
10-Q · filed 2013-10-28
$9.57M
derived: sum of 4 quarters · filed 2014-02-26
2012-06-30$2.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29
$4.24M
10-Q · filed 2013-07-29
$5.18M
derived: sum of 3 quarters · filed 2014-02-26
$5.63M
derived: sum of 4 quarters · filed 2014-02-26
2012-03-31$1.39M
10-Q · filed 2013-04-29
$2.33M
derived: sum of 2 quarters · filed 2014-02-26
$2.78M
derived: sum of 3 quarters · filed 2014-02-26
$2.79M
derived: sum of 4 quarters · filed 2014-02-26
2011-12-31$943.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26
$1.39M
derived: sum of 2 quarters · filed 2014-02-26
$1.40M
derived: sum of 3 quarters · filed 2014-02-26
$1.96M
10-K · filed 2014-02-26
2011-09-30$450.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29
$459.00K
derived: sum of 2 quarters · filed 2012-10-29
$1.02M
10-Q · filed 2012-10-29
$1.88M
derived: sum of 4 quarters · filed 2013-02-26
2011-06-30$9.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
$569.00K
10-Q · filed 2012-08-02
$1.43M
derived: sum of 3 quarters · filed 2013-02-26
$2.12M
derived: sum of 4 quarters · filed 2013-02-26
2011-03-31$560.00K
10-Q · filed 2012-04-30
$1.42M
derived: sum of 2 quarters · filed 2013-02-26
$2.11M
derived: sum of 3 quarters · filed 2013-02-26
$1.41M
derived: sum of 4 quarters · filed 2013-02-26
2010-12-31$860.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
$1.55M
derived: sum of 2 quarters · filed 2013-02-26
$851.00K
derived: sum of 3 quarters · filed 2013-02-26
$1.90M
10-K · filed 2013-02-26
2010-09-30$693.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31
-$9.00K
derived: sum of 2 quarters · filed 2011-10-31
$1.04M
10-Q · filed 2011-10-31
$221.00K
derived: sum of 4 quarters · filed 2012-02-22
2010-06-30-$702.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01
$347.00K
10-Q · filed 2011-08-01
-$472.00K
derived: sum of 3 quarters · filed 2012-02-22
-$88.00K
derived: sum of 4 quarters · filed 2012-02-22
2010-03-31$1.05M
10-Q · filed 2011-04-29
$230.00K
derived: sum of 2 quarters · filed 2012-02-22
$614.00K
derived: sum of 3 quarters · filed 2012-02-22
2009-12-31-$819.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22
-$435.00K
derived: sum of 2 quarters · filed 2012-02-22
$687.00K
10-K · filed 2012-02-22
2009-09-30$384.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29
$1.51M
10-Q · filed 2010-10-29
2009-06-30$1.12M
10-Q · filed 2010-08-04
2008-12-31$78.00K
10-K · filed 2011-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05